My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: alliance management  alliances  collaboration  partnering  alliance  alliance managers  partners  partner  alliance manager  partnerships  ecosystem  The Rhythm of Business  partnership  Jan Twombly  governance  biopharma  Eli Lilly and Company  Vantage Partners  Strategic Alliance Magazine  IBM  IoT  ASAP BioPharma Conference  strategy  healthcare  NetApp  2015 ASAP Global Alliance Summit  Christine Carberry  Cisco  cloud  communication 

ASAP European Alliance Summit To Provide ‘Extensive Content’ to Expanding Number of Participants

Posted By Cynthia B. Hanson, Wednesday, November 2, 2016

What was just around the corner begins tomorrow, one of Europe’s most advanced educational business opportunities the 2016 ASAP European Alliance Summit. Held at London’s exquisite Royal Garden Hotel near Kensington Gardens, “The New Ecosystem for Partnerships” is being jointly sponsored by the Association of Strategic Alliance Professionals and Thought Leader Global.

The number of attending alliance managers and partnering practitioners is expected to double as compared to last year, providing ample opportunity to network. “This year’s ASAP European Alliance Summit is highly international and diverse with more than 100 participants confirmed so far,” said Ariann Ignati, operations manager at Thought Leader Global, which is known for arranging business media and events for senior management in multinational enterprises. “We have extensive content and presentations from the life sciences, IT, manufacturing, and many other industries,” including energy, smart cities, biopharma, engineering, chemical, and consumer goods.

An international contingent of around 30 progressive business thinkers from more than 15 countries will provide some of the most cutting edge information in their industries during two streams of programming. Presenters will cover the topics of cross-sector alliances, joint ventures, innovation, and ecosystem partnering; discuss in-house case studies; delve into the impact of the cloud, Internet of Things, and digital systems, among other topics. Session topics range from Google’s “An Alliance Built on Culture” to Facebook’s “New Partnership Models in a Digital Landscape,” Siemens Technology to Business’s “Innovation, Disruption and Partnerships within the Startup Ecosystem,” Ipsen’s “Developing an Onboarding Process for Alliances/Partnerships,” Janssen Business Development’s “Making your Alliance Global: Having a Global Approach for Managing Alliances,” and many more. Click here for an expanded list of of session and speaker information.

Sessions will be provided by heads of alliances and joint ventures, corporate partnering experts, and business development specialists, as well as alliance, JV, and partnership departments from companies such as IBM, Bayer, Facebook, Takeda, Philips, Johnson & Johnson, Cisco, Renault Nissan, Google, Deutsche Telekom, Unilever, GE Oil and Gas, Shell, DONG Energy, Sanofi, AstraZeneca, Syngenta, Huawei, Ericsson, Servier Monde, Janssen, Oracle, the Novo Nordisk Haemophilia Foundation, and New Generation Leader.

“It’s a critical time in alliance management as it adapts and grapples with the changing landscape of the emerging multi-industry ecosystem,” said Michael Leonetti, CSAP, president & CEO of ASAP. “This is an opportunity to jump in and hear from some of the biggest movers and shakers in their industries on how their companies are breaking from the pack to collaborate in innovative and adaptive ways as the Internet of Things impacts their partnering.”

Leonetti plans to attend the Summit, opening the event by making himself available to anyone interested in finding out how ASAP membership and best practices can enhance your business practices. Those who arrive early will have the opportunity to take the ASAP Certification of Achievement-Alliance Management (CA-AM) Prep Workshop on Wednesday, Nov. 2.

For more information and an expanded list of offerings, go to: http://www.strategic-alliances.org/?page=eurosummit

Tags:  2017 ASAP European Alliance Summit  alliance  alliance managers  cloud  cross-sector alliances  digital systems  Ecosystem  ecosystem partnering  innovation  Internet of Things  joint ventures  partnering  Partnerships  Thought Leader Global 

Share |
PermalinkComments (0)
 

Part IV: Stuart and Shawn Compare Notes on How to Build Bridges among Partners though Best Tools and Practices

Posted By Cynthia B. Hanson, Tuesday, October 25, 2016
Updated: Saturday, October 22, 2016

This is our continued coverage of a lively discussion that took place at an ASAP session presenting two valuable alliance management studies on “Applying the Latest Alliance Management Research to Your Partnering Practice” at the 2016 ASAP BioPharma Conference “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed,” which took place at the Revere Hotel in Boston. The session unveiled the landmark ASAP-commissioned 6th State of Alliance study, “The Economics of Alliances, Social Capital, and Alliance Performance,” researched and authored by Dr. Shawn Wilson, DBA, vice president and general manager at Beaulieu Group (see Part I of this blog post). The session also included an insightful presentation by Stuart Kliman, CA-AM, co-founder of Vantage Partners, on his company’s 2015 study “Transcending Organizational Barriers—A Cross-Industry View of Alliance Management Trends and Challenges” (see Part II of this blog post). The presenters then engaged in a conversation about how the two studies dovetail in economic and financial metrics and the ways they can be used to improve company performance (see Part III of this blog post).  

Shawn: It goes back to the ability to build bridges. There are some families in a neighborhood that exert more effort to make community ties. The same thing is true with tools and practicessome are more helpful in building bridges between companies. We need to look at how we are assessing companies and whether we are missing a large mass of information underneath. The full picture needs to be looked at so the bridge you are building can match up to the distance. There was a small business worth billion of dollars, struggling to hit two-to-three percent growth. We looked at social capital, and a little sliver came out that seems trivial, but we employed it into a solution. That little sliver went live two months ago and resulted in 80 percent growth. Social capital might seem small, but it is clearly a force driving firms away or pulling them together.

Stuart:  You need to put in mechanisms to bridge the difference.

Shawn: Sometimes the gap is too big. You need to ask: “Do we actually have the capability?” Building a plane while in the air is not the best strategy.

Stuart: Sometimes we get called in to intervene in an alliance. Someone will call and say we have lost trust. What does that mean? We don’t trust that we are well aligned, have the ability to manage that misalignment, and be able to manage that difference in a significant way. They think of trust as individual relationships.

Shawn: Social capital is not so much the existence of specific ties. It’s more the environment created for them to exist that’s definitely a spider web. There is too much emphasis put on goodwill and trust. Social capital is not these feelings or soft things or upper-level management having strong personal deals. It’s about two firms having multiple connections. It’s about the structural dimensions and the ability to interact. Last in line in social capital are the trust, respect, and goodwill. 

Tags:  alliance management research studies  Alliance Maturity  Dr. Shawn Wilson  Economic Metrics  Social Capital  Stuart Kliman  Vantage Partners 

Share |
PermalinkComments (0)
 

Part III: Stuart and Shawn’s Economic and Financial Metrics—A Dialogue About Social Capital and Alliance Maturity

Posted By Cynthia B. Hanson, Monday, October 24, 2016
Updated: Saturday, October 22, 2016

ASAP presented first-of-their-kind findings from two alliance management research studies during the packed session  “Applying the Latest Alliance Management Research to Your Partnering Practice” at the 2016 ASAP BioPharma Conference “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed,” which took place at the Revere Hotel in Boston. The session unveiled the landmark ASAP-commissioned 6th State of Alliance study, The Economics of Alliances, Social Capital, and Alliance Performance,” researched and authored by Dr. Shawn Wilson, DBA, vice president and general manager at Beaulieu Group (see Part I of this story posted on September 14).

The session also included an insightful presentation by Stuart Kliman, CA-AM, co-founder of Vantage Partners, on his company’s 2015 study “Transcending Organizational Barriers—A Cross-Industry View of Alliance Management Trends and Challenges” (see Part II of this blog post). The presenters then engaged in a conversation about how the two studies dovetail in economic and financial metrics and the ways they can be used to improve company performance. Following is part of their exchange:

Stuart: I think the two studies are very well connected and say very similar things in different ways. One thing that is interesting is that internal operating models haven’t evolved at the same pace as alliancing activity. In the gaps in the internal operating models, we need to rely on social capital. If you start to think of social capital and operating models, organizations need to grapple with how to enable the building of social capital. It’s not easy to do if organizations put people in dilemmas to make social capital decline. The concern I have about the ASAP study is that the language of social capital sounds too individual skill-based, not “How do we build up organizational capability?” We need to make sure executives don’t misunderstand that language.

Shawn: Social capital is an extremely underused term that is much more than individual ties. It’s been used for relationship building, but it’s really precise with dimensions that are unique and powerful when employed…. You need to take all those things into account to appropriately assess the distance between two firms: Is the social capital strong enough to put them together? How do firms assess maturity?

Stuart: Alliance management maturity is a useful concept, and how social capital fits into the model or how to evolve it. Do we assume the commercialization process is taking place only internally, or through partner relationships? There are various attributes of maturity, and when you measure maturity, you want to define your terms. Assuming you have a complex portfolio of somewhat interdependent relationships, what is your maturity level to manage that kind of social capital? Below the surface activities are really interesting to understand, and how they keep us from delivering specific goals.

Shawn: Alliances are outpacing the ability to properly apply physical techniques and analyze, and it’s important to understand the true distance between two companies. How do firms build social capital? That’s a fantastic question. Consider this analogy: My wife and I located back to the West Coast and moved to a neighborhood with an eclectic group—PhDs, opera signers, government workers. If you’d asked me whom the people were that I’d connect with, it wouldn’t have been these folks. But it turns out the structural dimension of the neighborhood was key—who was out in the front yard every night and what is family to me were much stronger predictors of connections.

Stay tuned for additional coverage of the session “Applying the Latest Alliance Management Research to Your Partnering Practice,” which will continue the lively discussion in Part IV between the presenters on how the two studies connect. You can read more on Vantage’s studies by visiting https://www.vantagepartners.com/Articles.aspx

Tags:  Alliance Management  alliance management research studies  Alliance Maturity  alliances  Dr. Shawn Wilson  Economic Metrics  operating models  Social Capital  structural dimension  Stuart Kliman  Vantage Partners 

Share |
PermalinkComments (0)
 

Valuable Economic and Financial Metrics to Support Partnering and Revenues, Part II: How Companies Underestimate Alliance Challenges—Especially When Their Operating Model Is the Barrier

Posted By Cynthia B. Hanson, Thursday, October 6, 2016
Updated: Wednesday, October 5, 2016

Alliance management workers and their associated crew members had the opportunity to stock their toolboxes with valuable building instructions at a unique session, “Applying the Latest Alliance Management Research to Your Partnering Practice,” at the ASAP 2016 BioPharma Conference, “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed,” which took place Sept. 7-9 at the Revere Hotel in Boston. The session included a presentation by Stuart Kliman, CA-AM, co-founder of Vantage Partners, on the key findings from Vantage’s 2015 study “Transcending Organizational Barriers—A Cross-Industry View of Alliance Management Trends and Challenges.” The deep dive was part of a two-part presentation that included the findings of Dr. Shawn Wilson, DBA, who introduced an ASAP-commissioned 6th State of Alliance study, “The Economics of Alliances, Social Capital, and Alliance Performance,” which was covered in my previous Part I blog post

“Our findings show that companies are actually doing okay. There aren’t giant failure rates taking place,” observed Stuart Kliman, CA-AM, co-founder of Vantage Partners, during his presentation of Vantage Partners’ latest comprehensive cross-industry study on alliances and alliance management. The 2015 study probes alliance prevalence and success rates through a two-part study methodology that included a 500-respondent survey and practitioner interviews. “ASAP would have been failing if those failure rates hadn’t [improved] over the last several years. Organizations have built up partnering capability, and that has had an impact on success rates.”

Kliman then zeroed in more specifically on the intent of the study: to determine the significance of alliance execution challenges and their consequences; the impact of alliance management maturity on success rates; and potential underlying organizational root causes of alliance execution challenges.

“People still identify alliance execution issues as being the foremost disabler in reaching alliance goals,” he explained of the impetus of the study. “They can identify significant loss of value through poor execution of those issues and spend a lot of time dealing with conflict. Shawn’s iceberg continues to be the underminer of execution.” [Part I of this blog post focuses on Dr. Shawn Wilson’s key findings, which included an “iceberg” analogy of how company issues can be hidden underwater, impacting social capital.]

The purpose of a merger is to eliminate difference, “but alliances are a different ‘berg,” he noted. “Organizations continue to significantly underestimate how challenging they can be. … Internal operating models haven’t evolved in a way consistent with how important alliances are becoming to our strategy.”

Alliance execution was identified in the study as the most frequent cause of alliance failure. Kliman linked that challenge to Wilson’s presentation. “Biopharma companies have internal innovation models, but they don’t spend a lot of time grappling. We actually have organizations involved in partnerships that haven’t evolved over time, so alliance management groups spend a lot of time putting ‘Band-Aids’ on organizations that are regularly undermining execution,” he observed.

He then explained more about the purposes of Vantage’s study:

  • To gain insight into the impact of ineffective management on alliance results
  • Identify new and persistent alliance execution challenges
  • Test hypotheses about the root causes of alliance management challenges

And the key findings of the study…

  • Organizations are increasingly leveraging partnerships to develop relationships for mutual gain, address business challenges, and drive bottom-line results.
  • Some 89 percent of pharma/biopharma respondents consider alliances “very important” or “mission critical.”
  • Some 83 percent of respondents reported having more alliances than five years ago.
  • Some 94 percent of respondents reported effective alliance management substantially increases the likelihood of, or is essential to, successful alliance execution.
  • The respondents reported that 39 percent of alliances fully achieved their objectives, 42 percent partially achieved their objectives, and 19 percent generally failed to achieve their objectives.

When higher maturity and capability grows, there are higher success rates, Kliman concluded. “This is where alliance management groups will lead the way:  One aspect of alliance management groups is to provide direct support to individual alliances and drive the capability. The next big goal is the focus in our second mission: To drive capability with alliances in mind.”

Stay tuned for additional coverage of the session “Applying the Latest Alliance Management Research to Your Partnering Practice,” which will focus on a lively discussion between the presenters and audience participants on how the two studies connect. You can read more on Vantage’s studies by visiting https://www.vantagepartners.com/Articles.aspx

Tags:  6th State of Alliance  alliance execution challenges  alliance execution issues  Alliance Management  alliance prevalence  alliances  biopharma  Dr. Shawn Wilson  management  Stuart Kliman  success rates  Vantage Partners 

Share |
PermalinkComments (0)
 

ASAP BioPharma Conference Keynoter Dr. Sam Nussbaum: ’An Industry under Siege Must Take on a Different Social Contract’

Posted By John W. DeWitt, Wednesday, October 5, 2016

A couple of weeks ago, renowned physician Dr. Samuel Nussbaum—who served as chief medical officer for Anthem through 16 years of dramatic change in the healthcare industry—took the stage at the Sept. 7-9, 2016 ASAP BioPharma Conference in Boston with a big grin, twinkling eyes, and an embrace of new ASAP Chairman Brooke Paige. Paige introduced Dr. Nussbaum and noted that speaking in Boston was a homecoming for “America’s Physician,” who trained in internal medicine at Massachusetts General and then in endocrinology at Harvard. Indeed, Nussbaum, who is now strategic consultant for EGB Advisors, paid homage to the Boston and Cambridge, Mass., area’s medical science history and still-expanding potential for academic partnerships.

“One only has to go a few blocks west of here to see where Merck began to work with Harvard; Novartis has a research center near MIT in Cambridge,” Nussbaum noted. Then he turned serious. “It’s great to be here,” he began, “but it’s also an extraordinary time in healthcare, an industry, a space, under siege. It’s no longer fully understandable to say we discover, we cure, we make health better for the world. One has to take on a different social contract … and drive collaboration.”

Nussbaum echoed Dickens’ famous description of the Elizabethan era in England.

“We live at a time which is unprecedented. It’s the best of times, because we are in an age of unprecedented advances in medical technology and human science, yet it’s the worst of times, because we have a healthcare system in the US and around the world that doesn’t provide access for everyone. The state of public health is not a focus; the quality of medical care doesn’t keep pace with the science. Looking back to halcyon days, we had a great healthcare system [in the US] and research leading to some of the most extraordinary advances in healthcare. Yet we have storm clouds on the horizon.”

Nussbaum discussed a variety of driving forces vs. restraining forces

  • Breakthrough science vs. affordability for government and private payers
  • Personalized medicine vs. reputation issues
  • Technology, big data, bioinformatics vs. value-based payment models, bundled payment
  • Patient-centered outcomes and clinical design vs. impact of consolidation

He juxtaposed several triumphs of modern medicine with what has become a key factor in recent news coverage of the pharma industry and in the run-up to 2016 US presidential election.

“Cardiac death rates dramatically reduced. Antiviral drugs transform HIV into a chronic illness vs. a killer. And screening and better drugs improve cancer survival. But there is anger, there is outrage,” over high-profile drug price increases in the US and lack of access in other places in the world. “Why are people so angry? Because they can’t afford, and as nations, we can’t afford, the cost of healthcare,” he said. “Over the last decade, the average US family wage hasn’t changed much—from $49,309 to $53,800. Why the movement to Sanders or Trump? Capitalizing on outrage.”

He further explained the context of this outrage—and why expanded coverage (in Massachusetts and across the US under Obama’s Affordable Care Act) hasn’t been the cure-all for healthcare in the US.

“Massachusetts was the first state to have universal coverage. It was done under ‘Romney Care,’ similar to ‘Obamacare,” he said. The problem? “In Massachusetts, healthcare costs went up $5.1 billion and everyone applauded that type of access. But look what happened to other essential services: public health spending down 40 percent; mental health spending down 33 percent, etc.” In other words, Nussbaum explained, “We stole from what are called the social determinants of health. We know that education and housing leads to better health and better health outcomes,” while costing less. In other words, prevention costs much less than the healthcare cure.

“More importantly,” Nussbaum continued, “we are not using our $3.2 billion wisely—30-40 percent of healthcare spending is wasted on unnecessary services, administrative costs, prices, fraud. This is what we have to contend with. That’s why it is about collaboration, why it is the focus of the Obama administration, and of private business, to introduce reforms.”

Don’t miss “Dr. Sam Nussbaum: Healing the US Healthcare System One Politician at a Time,” my colleague Genevieve Fraser’s previous blog coverage of Dr. Nussbaum’s keynote address

Tags:  Anthem  ASAP BioPharma Conference  big data  bioinformatics  Brooke Paige  bundled payment  Dr. Samuel Nussbaum  driving forces vs. restraining forces  EGB Advisors  Harvard  healthcare  Merck  MIT  Novartis  Personalized medicine  reputation issues  Technology  value-based payment models 

Share |
PermalinkComments (0)
 
Page 35 of 86
 |<   <<   <  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  >   >>   >| 
For more information email us at info@strategic-alliances.org or call +1-781-562-1630